期刊文献+

沙参麦冬汤治疗晚期肺癌的价值研究 被引量:10

Study on the Value of Modified Shashen Maidong Decoction in the Treatment of Advanced Lung Cancer
在线阅读 下载PDF
导出
摘要 目的分析晚期肺癌应用沙参麦冬汤加减治疗的临床价值。方法选取2016年1月—2017年12月收治的70例晚期肺癌患者为研究对象,摸球法分组,对照组35例应用GP方案治疗,研究组35例在对照组基础上联合沙参麦冬汤加减治疗,比较2组患者的总有效率、不良反应发生率及治疗后生活质量评分。结果研究组患者不良反应发生率为2.86%,低于对照组17.14%,差异有统计学意义(χ2=3.968,P<0.05),治疗前疼痛评分、生活质量评分比较,无统计学差异(P>0.05),治疗后,研究组患者治疗后生活质量评分(92.4±3.7)分比对照组(90.1±2.6)分高,疼痛评分(3.2±0.4)分低于对照组(4.6±0.7)分,差异有统计学意义(P<0.05)。结论晚期肺癌患者应用沙参麦冬汤加减治疗,患者临床疼痛症状改善显著,不良反应少,提高了患者生活质量,具有推广价值。 Objective To analyze the clinical value of modified Shashen Maidong decoction in the treatment of advanced lung cancer.Methods Seventy patients with advanced lung cancer admitted to our hospital from January 2016 to December 2017 were divided into two groups.The control group(35 cases)was treated with GP regimen.The study group(35 cases)was treated with Shashen Maidong decoction on the basis of the control group.The total effective rate,incidence of adverse reactions and quality of life after treatment were compared between the two groups.Results The incidence of adverse reactions in the study group was 2.86%,which was lower than 17.14%in the control group.The difference was statistically significant(X2=3.968,P<0.05).There was no significant difference in pain score and quality of life score before treatment(P>0.05).After treatment,the scores of QOL in the study group(92.4±3.7)were higher than those in the control group(90.1±2.6),and the pain score(3.2±0.4)was lower than that in the control group(4.6±0.7).The difference was statistically significant(P<0.05).Conclusion Modified Shashen Maidong decoction in the treatment of advanced lung cancer can significantly improve the clinical pain symptoms,has fewer adverse reactions,improve the quality of life of patients with value of promotion.
作者 查红群 邹红 曾灵芝 CHA Hongqun;ZOU Hong;ZENG Lingzhi(Pharmacy Department,Jiujiang First People's Hospital,Jiangxi Province,Jiujiang 332000,China;Dispensary of Traditional Chinese Medicine,Jiujiang First People's Hospital,Jiangxi Province,Jiujiang 332000,China;Oncology Department,Jiujiang First People's Hospital,Jiangxi Province,Jiujiang 332000,China)
出处 《中国中医药现代远程教育》 2018年第24期102-103,共2页 Chinese Medicine Modern Distance Education of China
关键词 沙参麦冬汤 晚期肺癌 生活质量评分 肺积 Shashen Maidong decoction advanced lung cancer scores of quality of life pulmonary retention
  • 相关文献

参考文献5

二级参考文献23

  • 1周际昌.实用肿瘤内科学[M].北京:人民卫生出版社.2006:47
  • 2杨宝峰.药理学[M].8版.北京:人民卫生出版社,2013:3.
  • 3Jemal A, Bray F, Center MM, et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 4Swanson S J, Herndon JE, D'Amico TA, et al. Video- assisted thoracic surgery lobectomy: RePort of CALGB 39802-a ProsPective, multi-institution feasibility study[J]. J Clin Oncol, 2007,25(31) : 4993-4997.
  • 5Goldstraw P,Growley J,Chansky K,et al. The LASLC Lung Cancer Staging Project:ProPosals for the revision of the TNM stage grouPings in the forthcoming (seventh) edition of the TNM of malignant tumours[J]. J Thorac Oncol, 2007,2(8) : 706-714.
  • 6D, Amico TA. ThoracoscoPic lobectomy: evolving and imProving[J]. J Thorac Cardiovasc Surg,2006,132(3):464- 465.
  • 7孙燕,周际昌.临床肿瘤内科手册[M].4版.北京:人民卫生出版社,2002:106—107.
  • 8陈鹊汀,王景凤,朱惠学,刘智勤,李中,于炳旗,胡庚坤.加味六君子汤对肿瘤术后化疗增效减毒的临床观察[J].医学研究与教育,2009,26(1):61-62. 被引量:3
  • 9郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量:561
  • 10朱树丽,王媛媛,张晓春.中医及中西医结合治疗小儿支原体肺炎进展[J].辽宁中医药大学学报,2012,14(6):250-252. 被引量:17

共引文献51

同被引文献94

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部